Amneal Pharmaceuticals Inc (AMRX)
5.97
+0.03
(+0.51%)
USD |
NASDAQ |
Apr 30, 11:37
Amneal Pharmaceuticals Debt to Equity Ratio: 133.49 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 133.49 |
| September 30, 2023 | 8.128 |
| June 30, 2023 | 8.612 |
| March 31, 2023 | 9.279 |
| December 31, 2022 | 9.120 |
| September 30, 2022 | 9.199 |
| June 30, 2022 | 9.904 |
| March 31, 2022 | 7.010 |
| December 31, 2021 | 7.628 |
| September 30, 2021 | 7.862 |
| June 30, 2021 | 8.055 |
| March 31, 2021 | 8.652 |
| December 31, 2020 | 9.288 |
| Date | Value |
|---|---|
| September 30, 2020 | 9.381 |
| June 30, 2020 | 9.252 |
| March 31, 2020 | 9.856 |
| December 31, 2019 | 11.34 |
| September 30, 2019 | 12.09 |
| June 30, 2019 | 5.746 |
| March 31, 2019 | 5.605 |
| December 31, 2018 | 5.254 |
| September 30, 2018 | 5.737 |
| June 30, 2018 | 5.542 |
| March 31, 2018 | |
| December 31, 2017 | -3.745 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
5.746
Minimum
Jun 2019
133.49
Maximum
Dec 2023
15.47
Average
9.199
Median
Sep 2022
Debt to Equity Ratio Benchmarks
| Fate Therapeutics Inc | 0.00 |
| Ocular Therapeutix Inc | 0.8222 |
| Editas Medicine Inc | 0.00 |
| AnaptysBio Inc | 0.00 |
| Stoke Therapeutics Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.473B |
| Total Liabilities (Quarterly) | 3.453B |
| Shareholders Equity (Quarterly) | 19.78M |
| Current Ratio | 1.628 |
| Net Debt Paydown Yield | 1.03% |